Host cell mTORC1 is required for HCV RNA replication.

Stöhr, Stefanie; Costa, Rui; Sandmann, Lisa; Westhaus, Sandra; Pfaender, Stephanie; Anggakusuma; Dazert, Eva; Meuleman, Philip; Vondran, Florian W R; Manns, Michael P; Steinmann, Eike; von Hahn, Thomas; Ciesek, Sandra

Name:

Stöhr et al.pdf

Size:

1.623Mb

Format:

PDF

Description:

Open Access publication

Download

Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.

Star rating

Your vote was cast
Thank you for your feedback

Authors

Stöhr, Stefanie
Costa, Rui
Sandmann, Lisa
Westhaus, Sandra
Pfaender, Stephanie
Anggakusuma
Dazert, Eva
Meuleman, Philip
Vondran, Florian W R
Manns, Michael P

Show all

Issue Date

2015-08-14

Metadata

Show full item record

Abstract

Chronically HCV-infected orthotopic liver transplantation (OLT) recipients appear to have improved outcomes when their immunosuppressive regimen includes a mammalian target of rapamycin (mTOR) inhibitor. The mechanism underlying this observation is unknown.

Citation

Host cell mTORC1 is required for HCV RNA replication. 2015: Gut

Affiliation

TWINCORE, Centre for Experimental and Clinical Infection Research; a joint venture between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Germany.

Type

Article

ISSN

1468-3288

Collections

publications of the research group virus transmission ([TC]VIRT)

The following license files are associated with this item: